STOCK TITAN
  1. Home
  2. News
  3. PKI

PerkinElmer to Present at Stifel Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

WALTHAM, Mass.--()--PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the Stifel Virtual Healthcare Conference on Tuesday, November 17, 2020 at 1:20 p.m. ET.

Jamey Mock, SVP and chief financial officer of PerkinElmer, will provide an update on the Company and its strategic priorities.

A live audio webcast of the presentation will also be available on the Investors section of the Company’s website at www.perkinelmer.com. A replay of the presentation will be posted on the PerkinElmer website after the event and will be available for 90 days following.

About PerkinElmer
PerkinElmer, Inc. is a global leader focused on innovating for a healthier world. The Company reported revenue of approximately $2.9 billion in 2019, has about 13,000 employees serving customers in 190 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.

Contacts

Investor Relations:
Bryan Kipp
+1-781-663-5583
Bryan.Kipp@perkinelmer.com

Media Relations:
Chet Murray
+1-781-663-5719
Chet.Murray@perkinelmer.com

Stock PKI logo
PKI

NYSE:PKI

PKI Rankings

N/A Ranked by Market Cap
N/A Ranked by Stock Gains
N/A Ranked by Dividends

PKI Latest News

Apr 29, 2024
Revvity Announces Financial Results for the First Quarter of 2024
Apr 25, 2024
Revvity Board Declares Quarterly Dividend
Apr 25, 2024
Revvity to Present at BofA Securities 2024 Health Care Conference
Apr 24, 2024
Revvity Unveils a New Era of Automated Tuberculosis Testing
Apr 15, 2024
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners

PKI Stock Data

14.46B
116.15M
0.27%
86.26%
2.79%
Analytical Laboratory Instrument Manufacturing
Manufacturing
Link
United States of America
Boston

About PKI

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique solutions to serve the diagnostics, life sciences, food, and applied markets. IT strategically partners with customers to enable earlier and more accurate insights supported by deep market knowledge and technical expertise. Its dedicated team of about 14,000 employees worldwide is passionate about helping customers work to create healthier families, improve the quality of life, and sustain the wellbeing and longevity of people globally. The Company reported revenue of approximately $3.8 billion in 2020, serves customers in 190 countries, and is a component of the S&P 500 index.